Regis Technologies Inc.
Doing business as Regis Chemical Company
- UEI
- CXP2QC5SGSM6
- CAGE
- 31ZF3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- registech.com
- Founded
- 1956
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$48 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Cellular membrane affinity chromatography kit for drug discovery | National Center for Complementary and Integrative Health (NIH) | $757,952 |
Similar vendors
About the company
Regis Technologies Inc., doing business as Regis Chemical Company, is a company that provides process and analytical development of small molecule APIs for pharmaceutical companies, as well as offering chromatography consumables. It is a self-certified small disadvantaged business, for-profit organization, manufacturer, and Subchapter S Corporation.
Through federal contract awards, Regis Technologies Inc. has primarily provided chromatography products and services to the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse. In 2020, they received a $36,911.25 purchase order for unspecified goods or services, with no set-aside designation applied. In 2019, they received a $21,072.22 firm fixed price purchase order for REFLECT I CELLULOSE C PREP COLUMN, again with no set-aside used, to support research at the National Institute on Drug Abuse.
Through federal grant awards, Regis Technologies Inc. received a $778,913.00 project grant in 2021 from the Department of Health and Human Services National Institutes of Health National Center for Complementary and Integrative Health. The grant is for the development of a cellular membrane affinity chromatography kit for drug discovery, which aims to create a novel kit using Regis' IAM.PC.DD2 columns to immobilize cell membrane fragments containing targeted proteins. This would allow for the identification of phytochemicals targeting transmembrane proteins from complex natural samples, accelerating drug discovery efforts targeting conditions like cancer, neurodegenerative diseases, chronic pain, and diabetes.
SBA capabilities narrative
Regis Technologies offers expertise in chemical synthesis and separations services from initial process development to commercial manufacturing. Regis also makes chromatography products for analytical chemistry.
Quick answers
Is Regis Technologies Inc. registered in SAM.gov?
Regis Technologies Inc.'s SAM.gov registration expired on March 10, 2026.
What is Regis Technologies Inc.'s most recent federal award?
Regis Technologies Inc.'s most recent federal grant award is Cellular membrane affinity chromatography kit for drug discovery (R41AT011716), from National Center for Complementary and Integrative Health (NIH), on July 1, 2021.
On GovTribe
See Regis Technologies Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors